Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Intraday Session

Author: Benzinga Insights | November 15, 2023 01:31pm

Gainers

  • Heron Therapeutics (NASDAQ:HRTX) stock moved upwards by 63.0% to $0.88 during Wednesday's regular session. As of 12:31 EST, Heron Therapeutics's stock is trading at a volume of 15.8 million, which is 750.5% of its average full-day volume over the last 100 days. The company's market cap stands at $123.8 million. The company's, Q3 earnings came out yesterday.
  • Kinnate Biopharma (NASDAQ:KNTE) shares increased by 57.32% to $2.47. The current volume of 55.3 million shares is 35889.2% of Kinnate Biopharma's average full-day volume over the last 100 days (last updated at 12:31 EST). The market value of their outstanding shares is at $116.3 million. As per the press release, Q3 earnings came out 4 days ago.
  • Mira Pharmaceuticals (NASDAQ:MIRA) stock moved upwards by 34.5% to $2.3. As of 12:31 EST, this security is trading at a volume of 913.3K shares, making up 1243.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $33.9 million.
  • Cormedix (NASDAQ:CRMD) stock moved upwards by 33.54% to $4.18. As of 12:31 EST, Cormedix's stock is trading at a volume of 6.3 million, which is 1245.5% of its average full-day volume over the last 100 days. The company's market cap stands at $229.1 million. As per the news, the Q3 earnings report came out yesterday.
  • Gossamer Bio (NASDAQ:GOSS) shares rose 30.09% to $0.81. Trading volume for this security as of 12:31 EST is 1.7 million, which is 87.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $182.5 million. The company's, Q3 earnings came out 4 days ago.
  • Evelo Biosciences (NASDAQ:EVLO) shares increased by 27.21% to $0.44. As of 12:31 EST, Evelo Biosciences's stock is trading at a volume of 2.9 million, which is 702.9% of its average full-day volume over the last 100 days. The company's market cap stands at $8.3 million. The company's, Q3 earnings came out 4 days ago.

Losers

  • Aytu BioPharma (NASDAQ:AYTU) stock fell 22.1% to $2.29 during Wednesday's regular session. Trading volume for Aytu BioPharma's stock is 217.6K as of 12:31 EST. This is 138.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $12.6 million. As per the press release, Q1 earnings came out yesterday.
  • Tivic Health Systems (NASDAQ:TIVC) stock declined by 17.74% to $1.79. Tivic Health Systems's stock is trading at a volume of 541.0K shares as of 12:31 EST. This is 34.4% of its average full-day volume over the last 100 days. The company's market cap stands at $2.6 million. The company's, Q3 earnings came out yesterday.
  • BioCardia (NASDAQ:BCDA) stock decreased by 16.92% to $0.89. BioCardia's stock is trading at a volume of 5.7 million shares as of 12:31 EST. This is 265.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $19.2 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) stock declined by 12.84% to $0.28. Trading volume for TransCode Therapeutics's stock is 1.5 million as of 12:31 EST. This is 26.2% of its average full-day volume over the last 100 days. The company's market cap stands at $5.5 million.
  • Homology Medicines (NASDAQ:FIXX) shares declined by 12.75% to $0.89. As of 12:31 EST, Homology Medicines's stock is trading at a volume of 561.5K, which is 364.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $51.4 million. As per the press release, Q3 earnings came out yesterday.
  • Intensity Therapeutics (NASDAQ:INTS) stock declined by 11.5% to $2.31. The company's market cap stands at $31.6 million. As per the press release, Q3 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AYTU BCDA CRMD EVLO FIXX GOSS HRTX INTS KNTE MIRA RNAZ TIVC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist